Sabby Management, LLC
- SEC CIK
- 0001535610
- Latest filing
- Aug 14, 2026
RNAZ holding history
Transcode Therapeutics, Inc. in every 13F filed by Sabby Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RNAZ overviewAll 13F holders of RNAZFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −229,052−100.0% | Sold out | Holders |
| Q1 2025 | 229,052 | $113.4K | 0.5% | +229,052 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −334,823−100.0% | Sold out | Holders |
| Q1 2024 | 334,823 | $228.7K | 1.5% | +334,823 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −250,309−100.0% | Sold out | Holders |
| Q3 2023 | 250,309 | $125.8K | 0.4% | +61,872+32.8% | Added | Holders |
| Q2 2023 | 188,437 | $433.4K | 1.6% | +188,437 | New | Holders |